Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cushman & Wakefield (CWK)

Cushman & Wakefield cuts interest rate on $840 million term loan by 25 basis points

Neutral Impact 3 of 5 financing Written later

Cushman & Wakefield's U.S. borrowing subsidiary amended its credit agreement, effective October 1, 2025, lowering the interest rate on about $840 million of term loan due January 2030 from Term SOFR plus 2.75% to Term SOFR plus 2.50%. The company said the maturity and other material terms are unchanged, and it reported $200 million of year-to-date debt repayment, including a $150 million prepayment on August 5, 2025.

Key points

  • Interest rate on about $840 million of term loan cut by 25 basis points, from Term SOFR plus 2.75% to Term SOFR plus 2.50%, effective October 1, 2025
  • Loan maturity remains January 2030; the amendment makes no other material changes to the credit agreement
  • Company prepaid $150 million of the term loan on August 5, 2025, bringing 2025 year-to-date repayment to $200 million and repayment since the start of 2024 to $400 million

The filing

CompanyCushman & Wakefield (CWK)
Form8-K, current report
Filed with the SECOct 2, 2025, 4:35 PM ET
Accession number0001193125-25-228460

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 02, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.